Related Experiment Video
Updated: Apr 19, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Paediatric rheumatology in 2014: Digging deeper for greater precision and more impact in JIA
Berent Prakken1, Alberto Martini2
1Department of Paediatric Immunology &Laboratory for Translational Immunology, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, Netherlands.
Insights
Optimizing childhood arthritis management needs personalized disease insights. Genetic studies and immunopathogenesis research in 2014 paved the way for clinical biomarkers and individualized therapy.
Area of Science:
- Pediatric Rheumatology
- Immunogenetics
- Translational Medicine
Background:
- Effective management of childhood arthritis necessitates a deep understanding of individual patient disease characteristics.
- Recent advancements are crucial for developing targeted treatment strategies.
Purpose of the Study:
- To explore how genetic studies and immunopathogenesis insights can inform clinical practice.
- To highlight the potential for developing individualized therapies for childhood arthritis.
Main Methods:
- Review of genetic studies published in 2014.
- Analysis of immunopathogenesis research.
- Evaluation of the translation of research findings into clinical biomarkers.
Main Results:
- In-depth genetic investigations offer valuable insights into disease mechanisms.
- Understanding immunopathogenesis is key to identifying therapeutic targets.
- The potential for developing clinical biomarkers from these studies is significant.
Conclusions:
- Advances in genetic and immunopathogenesis research are critical for optimizing childhood arthritis management.
- These insights are expected to lead to the development of individualized therapeutic approaches.
Abstract:
Optimizing the management of childhood arthritis requires detailed knowledge of the disease in an individual patient. Advances in 2014 show how in-depth genetic studies and insights into immunopathogenesis could translate into clinical biomarkers and, eventually, individualized therapy.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
The JAK-STAT Signaling Pathway
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...

